219 related articles for article (PubMed ID: 22082330)
41. Treatment considerations for bacterial vaginosis and the risk of recurrence.
Chen JY; Tian H; Beigi RH
J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
[TBL] [Abstract][Full Text] [Related]
42. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
Aroutcheva AA; Simoes JA; Behbakht K; Faro S
Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
[TBL] [Abstract][Full Text] [Related]
43. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
[TBL] [Abstract][Full Text] [Related]
45. [The bacterial vaginosis--treatment problems].
Romanik MK; Ekiel AM; Tomana L; Martirosian G
Wiad Lek; 2007; 60(1-2):64-7. PubMed ID: 17607971
[TBL] [Abstract][Full Text] [Related]
46. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole.
Swidsinski A; Mendling W; Loening-Baucke V; Swidsinski S; Dörffel Y; Scholze J; Lochs H; Verstraelen H
Am J Obstet Gynecol; 2008 Jan; 198(1):97.e1-6. PubMed ID: 18005928
[TBL] [Abstract][Full Text] [Related]
47. Self-collected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis.
Menard JP; Fenollar F; Raoult D; Boubli L; Bretelle F
Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):513-8. PubMed ID: 21789604
[TBL] [Abstract][Full Text] [Related]
48. Screening of Compounds against Gardnerella vaginalis Biofilms.
Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
[TBL] [Abstract][Full Text] [Related]
49. Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae.
Verstraelen H; Verhelst R; Nuytinck L; Roelens K; De Meester E; De Vos D; Van Thielen M; Rossau R; Delva W; De Backer E; Vaneechoutte M; Temmerman M
J Reprod Immunol; 2009 Jan; 79(2):163-73. PubMed ID: 19200604
[TBL] [Abstract][Full Text] [Related]
50. Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.
Mollin A; Katta M; Sobel JD; Akins RA
PLoS One; 2022; 17(7):e0272012. PubMed ID: 35901180
[TBL] [Abstract][Full Text] [Related]
51. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria.
Mitchell CM; Hitti JE; Agnew KJ; Fredricks DN
BMC Infect Dis; 2009 Jun; 9():89. PubMed ID: 19515236
[TBL] [Abstract][Full Text] [Related]
52. [Atopobium vaginae: characterization and association with pathogenesis of bacterial vaginosis].
Romanik M; Friedek D; Wojciechowska-Wieja A; Martirosian G
Ginekol Pol; 2006 May; 77(5):398-403. PubMed ID: 16958231
[TBL] [Abstract][Full Text] [Related]
53. Bacterial vaginosis.
Priestley CJ; Kinghorn GR
Br J Clin Pract; 1996 Sep; 50(6):331-4. PubMed ID: 8983322
[TBL] [Abstract][Full Text] [Related]
54. Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible?
Shipitsyna E; Roos A; Datcu R; Hallén A; Fredlund H; Jensen JS; Engstrand L; Unemo M
PLoS One; 2013; 8(4):e60670. PubMed ID: 23585843
[TBL] [Abstract][Full Text] [Related]
55. Rapid detection of Atopobium vaginae and association with organisms implicated in bacterial vaginosis.
Trama JP; Pascal KE; Zimmerman J; Self MJ; Mordechai E; Adelson ME
Mol Cell Probes; 2008 Apr; 22(2):96-102. PubMed ID: 17913456
[TBL] [Abstract][Full Text] [Related]
56. Report on Gardnerella vaginitis.
Schell CL; Harris JH; Honkanen AA; Edwards MS; Raia TJ
Mil Med; 1992 Jan; 157(1):37-40. PubMed ID: 1603376
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of Gardnerella vaginalis and Atopobium vaginae in Portuguese women and association with risk factors for bacterial vaginosis.
Silva D; Henriques A; Cereija T; Martinez-de-Oliveira J; Miranda M; Cerca N
Int J Gynaecol Obstet; 2014 Feb; 124(2):178-9. PubMed ID: 24268352
[No Abstract] [Full Text] [Related]
58. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of Gardnerella vaginalis and Atopobium vaginae in virginal women.
Tabrizi SN; Fairley CK; Bradshaw CS; Garland SM
Sex Transm Dis; 2006 Nov; 33(11):663-5. PubMed ID: 16601662
[TBL] [Abstract][Full Text] [Related]
60. Clinical effects of nifuratel in vulvovaginal infections. A meta-analysis of metronidazole-controlled trials.
Mendling W; Poli A; Magnani P
Arzneimittelforschung; 2002; 52(10):725-30. PubMed ID: 12442634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
